Literature DB >> 25137631

Low-density lipoprotein-mimicking nanoparticles for tumor-targeted theranostic applications.

Jeong Yu Lee1, Jin-Ho Kim, Ki Hyun Bae, Mi Hwa Oh, Youngwook Kim, Jee Seon Kim, Tae Gwan Park, Keunchil Park, Jung Hee Lee, Yoon Sung Nam.   

Abstract

This study introduces multifunctional lipid nanoparticles (LNPs), mimicking the structure and compositions of low-density lipoproteins, for the tumor-targeted co-delivery of anti-cancer drugs and superparamagnetic nanocrystals. Paclitaxel (4.7 wt%) and iron oxide nanocrystals (6.8 wt%, 11 nm in diameter) are co-encapsulated within folate-functionalized LNPs, which contain a cluster of nanocrystals with an overall diameter of about 170 nm and a zeta potential of about -40 mV. The folate-functionalized LNPs enable the targeted detection of MCF-7, human breast adenocarcinoma expressing folate receptors, in T2 -weighted magnetic resonance images as well as the efficient intracellular delivery of paclitaxel. Paclitaxel-free LNPs show no significant cytotoxicity up to 0.2 mg mL(-1) , indicating the excellent biocompatibility of the LNPs for intracellular drug delivery applications. The targeted anti-tumor activities of the LNPs in a mouse tumor model suggest that the low-density lipoprotein-mimetic LNPs can be an effective theranostic platform with excellent biocompatibility for the tumor-targeted co-delivery of various anti-cancer agents.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  anti-cancer agents; imaging; low-density lipoproteins; nanoparticles; self-assembly

Mesh:

Substances:

Year:  2014        PMID: 25137631     DOI: 10.1002/smll.201303277

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  9 in total

1.  Low-density lipoprotein encapsulated thiosemicarbazone metal complexes is active targeting vehicle for breast, lung, and prostate cancers.

Authors:  Laila Jaragh-Alhadad; Mayada Samir; Terri J Harford; Sadashiva Karnik
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 2.  Inorganic nanoparticles in diagnosis and treatment of breast cancer.

Authors:  Cristina Núñez; Sergio Vázquez Estévez; María Del Pilar Chantada
Journal:  J Biol Inorg Chem       Date:  2018-02-16       Impact factor: 3.358

Review 3.  Biomimetics: reconstitution of low-density lipoprotein for targeted drug delivery and related theranostic applications.

Authors:  Chunlei Zhu; Younan Xia
Journal:  Chem Soc Rev       Date:  2017-12-11       Impact factor: 54.564

4.  Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel.

Authors:  Junyi Qian; Ningze Xu; Xu Zhou; Kaihong Shi; Qian Du; Xiaoxing Yin; Ziming Zhao
Journal:  Int J Nanomedicine       Date:  2019-09-11

5.  Assembly of Iron Oxide Nanocubes for Enhanced Cancer Hyperthermia and Magnetic Resonance Imaging.

Authors:  Minjung Cho; Antonio Cervadoro; Maricela R Ramirez; Cinzia Stigliano; Audrius Brazdeikis; Vicki L Colvin; Pierluigi Civera; Jaehong Key; Paolo Decuzzi
Journal:  Nanomaterials (Basel)       Date:  2017-03-28       Impact factor: 5.076

6.  Lipoproteins modulate growth and P-glycoprotein expression in drug-resistant HER2-overexpressed breast cancer cells.

Authors:  Z S Siti; A M I Seoparjoo; H Shahrul
Journal:  Heliyon       Date:  2019-04-28

7.  Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel-cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines.

Authors:  Jun Ye; Xuejun Xia; Wujun Dong; Huazhen Hao; Luhua Meng; Yanfang Yang; Renyun Wang; Yuanfeng Lyu; Yuling Liu
Journal:  Int J Nanomedicine       Date:  2016-08-24

8.  Inorganic Kernel-Reconstituted Lipoprotein Biomimetic Nanovehicles Enable Efficient Targeting "Trojan Horse" Delivery of STAT3-Decoy Oligonucleotide for Overcoming TRAIL Resistance.

Authors:  Kai Shi; Jianxiu Xue; Yan Fang; Hongshu Bi; Shan Gao; Dongjuan Yang; Anqi Lu; Yuai Li; Yao Chen; Liyuan Ke
Journal:  Theranostics       Date:  2017-10-12       Impact factor: 11.556

Review 9.  Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer.

Authors:  Chun Yang; Stéphane Croteau; Pierre Hardy
Journal:  Cell Oncol (Dordr)       Date:  2021-07-27       Impact factor: 7.051

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.